 |
Also known as: Macugen
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Pegaptanib.
No reviews have yet been submitted. Be the first to review this drug.
Pregnancy Category No proven risk in humans
Using human embryonic stem cells to treat the eye disease macular degeneration appears to be safe and leads to some vision improvement, a small, early-stage...
Daily aspirin use among seniors may double their risk of developing a particularly advanced form of age-related macular degeneration, a debilitating eye...
Patients in the EYLEA 2mg every eight week group achieved visual acuity gains similar to ranibizumab with 5 fewer injections, on average, over two...
Comprehensive Phase 1a and b Findings for Novel, Oral Compound for Dry AMD to be Highlighted Seattle, Washington and Vienna, Austria (November 30,...
Comprehensive Phase 1a and b Findings for Novel, Oral Compound for Dry AMD to be Highlighted SEATTLE & VIENNA--(BUSINESS WIRE)--Nov 30, 2011 - Acucela...
Looking for answers? Ask a question or go join the pegaptanib support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
